Comparative efficacy and acceptability of licensed dose intranasal corticosteroids for moderate-to-severe allergic rhinitis: a systematic review and network meta-analysis

No evidence shows that one intranasal corticosteroid (INCS) is better than another for treating moderate-to-severe allergic rhinitis (AR). This network meta-analysis assessed the comparative efficacy and acceptability of licensed dose aqueous INCSs. PubMed/MEDLINE, Scopus, EMBASE, and the Cochrane C...

Descripción completa

Detalles Bibliográficos
Autores principales: Soe, Kay Khine, Krikeerati, Thanachit, Pheerapanyawaranun, Chatkamol, Niyomnaitham, Suvimol, Phinyo, Phichayut, Thongngarm, Torpong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242043/
https://www.ncbi.nlm.nih.gov/pubmed/37288109
http://dx.doi.org/10.3389/fphar.2023.1184552

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242043/
https://www.ncbi.nlm.nih.gov/pubmed/37288109
http://dx.doi.org/10.3389/fphar.2023.1184552

Ejemplares similares